Equity

BlackRock World Healthscience Fund

IMPORTANT:
•The Fund's investments in equities could incur significant losses due to higher fluctuation of equity values. The Fund’s investments are concentrated in the healthcare, pharmaceuticals and other healthscience sectors. This may result in greater volatility than more broad-based investments.
•The Fund is subject to currency risk, emerging market risk, foreign investments restrictions risk, small-cap companies’ volatility and liquidity risks and currency conversion risk including Renminbi denominated Classes.
•The Fund may use derivatives for hedging and for investment purposes. However, usage for investment purposes will not be extensive. The Fund may suffer losses from its derivatives usage.
•The value of the Fund can be volatile and can go down substantially within a short period of time. It is possible that a certain amount of your investment could be lost.
•Investors should not make investment decisions based on this document alone. Investors should refer to the Prospectus and Key Facts Statement for details including risk factors.

Overview

Loading

All currency hedged share classes of this fund use derivatives to hedge currency risk. The use of derivatives for a share class could pose a potential risk of contagion (also known as spill-over) to other share classes in the fund. The fund’s management company will ensure appropriate procedures are in place to minimise contagion risk to other share class. Using the drop down box directly below the name of the fund, you can view a list of all share classes in the fund – currency hedged share classes are indicated by the word “Hedged” in the name of the share class. In addition, a full list of all currency hedged share classes is available on request from the fund’s management company

Performance

Performance

Chart

Performance chart data not available for display.
View Charts & Calendar Year Performance
  1y 3y 5y 10y Incept.
21.25 13.52 11.82 14.76 10.76
Benchmark (%)

as of 30-Sep-2020

20.81 10.63 9.90 13.08 9.44
  YTD 6m 1y 3y 5y 10y Incept.
7.62 20.93 21.25 46.30 74.82 296.16 273.33
Benchmark (%)

as of 30-Sep-2020

6.26 20.03 20.81 35.42 60.33 241.83 219.75
Past performance is not a guide to future performance. Investors may not get back the full amount invested.

Performance is calculated based on the period NAV-to-NAV with dividend reinvested. Performance figures are calculated net of fees.

These figures show by how much the Share Class of the Fund increased or decreased in value during the period being shown. Performance is calculated in the relevant share class currency, including ongoing charges and taxes and excluding subscription and redemption fees, if applicable.

Where no past performance is shown there was insufficient data available in that period to provide performance.

Please refer to the Key Facts section for the inception date of the Fund and the Share Class.
Why invest in healthcare equities?
Healthcare is a “defensive growth” sector. It is resilient in late cycle and recessionary periods. Furthermore, the aging population creates a growing demand for healthcare and has been a driver for the sector’s growth.
Watch video now Watch video now
Why invest in healthcare equities?

Key Facts

Key Facts

Size of Fund (Millions) as of 21-Oct-2020 USD 10,076.360 M
Base Currency USD
Fund Inception 06-Apr-2001
Share Class Currency USD
Share Class Inception Date 12-Nov-2007
Additional Currencies AUD, EUR, GBP, HKD, JPY, RMB, SGD
Asset Class Equity
Morningstar Category Sector Equity Healthcare
Benchmark Index MSCI World Health Care Index
Distribution Frequency Non-Distributing
ISIN LU0329593007
Bloomberg Ticker MLWORHD
Management Fee (incl Distribution Fee, if any) 0.75%
Initial Charge 5.00%
For Fee details, please refer to the Fund Prospectus.
What is the impact of COVID-19 to the healthcare sector?
The pandemic has benefited the sector in various ways, like increasing demand for drugs, COVID-related products and online health services.
Watch video now Watch video now
What is the impact of COVID-19 to the healthcare sector?

Portfolio Characteristics

Portfolio Characteristics

P/E Ratio as of 30-Sep-2020 27.27
Average Market Cap (Millions) as of 30-Sep-2020 USD 113,318.3 M
Modified Duration as of 30-Sep-2020 0.01 yrs
12M Trailing Distribution as of - -
3y Volatility as of 30-Sep-2020 14.53
3y Volatility - Benchmark as of 30-Sep-2020 14.46
3y Beta as of 30-Sep-2020 0.972
5yr Volatility as of 30-Sep-2020 13.84
5y Volatility - Benchmark as of 30-Sep-2020 13.26
5y Beta as of 30-Sep-2020 1.008
Since Class Inception – Volatility as of 30-Sep-2020 14.80
Since Class Inception Volatility – Benchmark as of 30-Sep-2020 13.73
Since Class Inception - Beta as of 30-Sep-2020 0.98

Ratings

Ratings

Morningstar Rating

5
As of 30-Sep-2020

Morningstar Analyst Rating

Morningstar Analyst Rating - Bronze
Effective 04-Dec-2019
Morningstar, Inc. All Rights Reserved.

Holdings

Holdings

as of 30-Sep-2020
Name Weight (%)
ABBOTT LABORATORIES 4.98
UNITEDHEALTH GROUP INC 4.87
SANOFI SA 3.91
ROCHE HOLDING PAR AG 3.65
JOHNSON & JOHNSON 3.60
Name Weight (%)
THERMO FISHER SCIENTIFIC INC 2.89
BOSTON SCIENTIFIC CORP 2.69
PFIZER INC 2.46
STRYKER CORP 2.21
AMGEN INC 2.05
The Fund is actively managed and its composition will vary. Holdings shown are for illustrative purposes only and should not be deemed as a recommendation to buy or sell the securities listed. Fund details, holdings and characteristics are as of the date noted and subject to change.
Holdings subject to change.

Exposure Breakdowns

Exposure Breakdowns

as of 30-Sep-2020

% of Weight

Type Fund Benchmark Net
Geographic exposure relates principally to the domicile of the issuers of the securities held in the product, added together and then expressed as a percentage of the product’s total holdings. However, in some instances it can reflect the geography where the issuer of the securities carries out much of their business. “Others” excluded from the chart above.
as of 30-Sep-2020

% of Weight

Type Fund Benchmark Net
as of 30-Sep-2020

% of Weight

Type Fund Benchmark Net
Allocations subject to change.
as of 30-Sep-2020

% of Weight

Type Fund Benchmark Net
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management. Allocations are subject to change.
Due to rounding, the total may not be equal to 100%

Pricing

Pricing

Share Class Currency Distribution Frequency NAV NAV $ Change NAV % Change NAV As Of 52wk High 52wk Low ISIN
D2 USD Non-Distributing 61.76 -0.26 -0.42 21-Oct-2020 63.47 43.41 LU0329593007
A4 EUR Annually 8.91 -0.07 -0.78 21-Oct-2020 9.37 6.91 LU2112291799
A4 USD Annually 10.57 -0.04 -0.38 21-Oct-2020 10.86 7.46 LU2112291526
D2 EUR Non-Distributing 52.07 -0.40 -0.76 21-Oct-2020 54.43 40.19 LU0827889485
D5 GBP Quarterly 10.94 -0.18 -1.62 21-Oct-2020 11.37 8.70 LU2112292763
A2 Hedged JPY Non-Distributing 1,211.00 -5.00 -0.41 21-Oct-2020 1,245.00 859.00 LU1948809360
A2 Hedged RMB Non-Distributing 159.60 -0.62 -0.39 21-Oct-2020 163.87 111.34 LU1254117382
A2 EUR Non-Distributing 47.20 -0.37 -0.78 21-Oct-2020 49.59 36.59 LU0171307068
A2 USD Non-Distributing 55.99 -0.23 -0.41 21-Oct-2020 57.55 39.52 LU0122379950
C2 EUR Non-Distributing 37.29 -0.29 -0.77 21-Oct-2020 39.51 29.12 LU0331289677
A2 Hedged EUR Non-Distributing 12.90 -0.05 -0.39 21-Oct-2020 13.26 9.18 LU1822774284
A2 Hedged SGD Non-Distributing 19.12 -0.08 -0.42 21-Oct-2020 19.66 13.56 LU1057294990
C2 USD Non-Distributing 44.23 -0.19 -0.43 21-Oct-2020 45.48 31.45 LU0147404148
A2 Hedged AUD Non-Distributing 18.95 -0.08 -0.42 21-Oct-2020 19.48 13.45 LU1023059063
A2 Hedged HKD Non-Distributing 192.81 -0.81 -0.42 21-Oct-2020 198.21 136.00 LU1061106388

Portfolio Managers

Portfolio Managers

Erin Xie
Erin Xie
Xiang Liu
Xiang Liu
Jeff Lee
Jeff Lee

Documents

Documents